Platelet Aggregation Clinical Trial
Official title:
Measurement of Platelet Dense Granule Release in Healthy Volunteers
Aspirin has been shown to reduce cardiovascular events in at risk individuals. Elucidation of mechanisms of aspirin resistance and a possible loss of effect of aspirin over time with chronic aspirin treatment necessitate a more precise method of measuring the "release phase" of platelet activation, including the release of dense granules from platelets.
This is a proposal for a pilot study to evaluate the feasibility of measuring
5-hydroxytryptamine (5-HT) release from platelets as an indicator of dense granule release
during platelet activation in volunteers taking aspirin.
One phase of platelet response to activating agonists involves release of dense granules,
which are known to contain 5HT (serotonin) and ATP. There are various methods of measuring
the degranulation of platelets: ATP release can be measured using a lumiaggregometer, and
release of 14C radiolabeled 5-HT from platelets. Using the aggregometer and a 14C labeled
5-HT assay can be used to measure 5-HT release from platelets.
Our experience suggests that ADP-induced ATP release is insensitive to detect very low
levels of platelet dense granule release, which occurs in aspirin-treated subjects. The
pilot study will permit optimizing the method for reliably detecting low levels of 5HT
release in patients who achieve submaximal inhibition of the cyclooxygenase during aspirin
treatment.
;
Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04492423 -
VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study
|
||
Completed |
NCT03355625 -
Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients
|
||
Completed |
NCT02958657 -
Effect of Exercise on Platelet Reactivity After Myocardial Infarction
|
N/A | |
Completed |
NCT01815008 -
Pharmacogenomics of Antiplatelet Response - I
|
Phase 4 | |
Completed |
NCT03039205 -
Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor
|
Phase 2 | |
Completed |
NCT01557335 -
A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540
|
Phase 1 | |
Completed |
NCT05581238 -
Validation of a Red Blood Cell Transfusion Prediction Model in a Low Transfusion Rate Population.
|
||
Completed |
NCT00233428 -
Study to Determine Racial and Gender Differences in Platelet Aggregation
|
Phase 1 | |
Completed |
NCT02112539 -
Aggreguide A-100 ADP Assay Evaluation
|
N/A | |
Completed |
NCT00923988 -
Effect of Passive Smoking on Platelet Function and Endothelial Function
|
N/A | |
Terminated |
NCT00748371 -
Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration
|
Phase 4 | |
Recruiting |
NCT05702463 -
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
|
Phase 1 | |
Recruiting |
NCT04842760 -
PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer
|
||
Recruiting |
NCT06236243 -
Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults
|
N/A | |
Completed |
NCT00763997 -
Study of the Effect of Dipyrone, Ibuprofen, Paracetamol and Parecoxib on the Platelet Aggregation in Analgetic Dosages
|
N/A | |
Active, not recruiting |
NCT03615846 -
Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan
|
||
Completed |
NCT04369534 -
Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction
|
Phase 4 | |
Completed |
NCT01603966 -
Low Dose Aspirin Studied With the AggreGuide
|
N/A | |
Completed |
NCT01152229 -
Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine
|
N/A | |
Recruiting |
NCT03528603 -
Acute Assessment of Platelet Reactivity After the Intake of Oleocanthal
|
N/A |